drugset / Trial / NCT02802969

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers

NCT02802969

Phase 2 Completed 64 enrolled Institut Curie
NaSingle-groupOpen-labelTreatment

Summary

Improved local control of chordoma initially treated with surgery or not, thanks to adjuvant radiotherapy oriented by conventional imaging Computed Tomography /Magnetic Resonance Imaging (CT / MRI) and guided by the \[18Fluor\] (\[18F\]) Fluoroazomycin Arabinofuranoside (FAZA) Positron Emission Tomography / Computed Tomography (PET / CT) to target the radioresistant hypoxic cells.

Timeline

Start
2016-07-22
Primary completion
2024-11-28
Completion
2024-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FAZA Diagnostic / imaging agent